Journal of Cardiovascular Research and Clinical Practice (jcrc) is an internationally reputed, peer-reviewed platform that highlights innovative studies and developments across the field of cardiovascular research and clinical practice. The journal serves as a channel for publishing significant contributions in Confseries along with other areas connected to cardiovascular research and clinical practice. jcrc welcomes original, evidence-based research articles that provide fresh insights, promote interdisciplinary cooperation, and advance both theoretical understanding and applied practices within the pharmaceutical sciences.
Authors may submit their manuscripts through the official online submission portal or by sending them directly via email to editorialoffice@confseries.net. Once the submission is received, the corresponding author will be assigned a unique manuscript identification number within three (3) business days. This reference number should be used to track the progress of the submission and for all subsequent correspondence.
In alignment with the NIH Public Access Policy, jcrc guarantees that articles supported by NIH funding are deposited in both PubMed and PubMed Central after publication. The same requirement extends to studies funded by the UK Research Councils and the European Union, reinforcing our commitment to open access, transparency, and broad dissemination of biomedical knowledge.
Every manuscript submitted to jcrc undergoes an initial editorial assessment, followed by a rigorous double-blind peer review. The journal welcomes a wide range of submissions, including original research articles, critical reviews, illustrative case studies, expert opinions, and methodological innovations. Authors are encouraged to enrich their manuscripts with supporting figures, tables, and graphics to improve readability and impact.
For contributors who require a quicker decision, jcrc offers an optional fast-track review service:
Authors preparing a manuscript for jcrc should ensure that the following documents are included with their submission:
All manuscripts submitted to jcrc are first evaluated by the editorial office to determine their relevance to the journal's scope, adherence to quality benchmarks, and compliance with ethical publishing standards. Approximately 70% of submissions that pass this initial review are then sent forward for external peer evaluation.
If revisions are required, authors will receive a formal decision letter summarizing the reviewer's recommendations. Revised manuscripts must be resubmitted within 7 days of receiving the notification. In exceptional cases, authors may request an extension in writing from the editorial office.
Submissions not revised and returned within the specified timeframe may be treated as withdrawn from the review process.
After acceptance, the corresponding author will be provided with galley proofs in PDF format by email for final verification. Authors should carefully review the file to correct any typographical, formatting, or factual errors. Please note that substantial modifications—such as changes to data, figures, or the author list—are not allowed at this stage.
Printed copies of the published article can be supplied on request. Authors wishing to obtain hard copies for personal reference or institutional distribution may contact the editorial office to make arrangements.
Publishing with ConfSeries Journals provides authors with worldwide visibility under a Gold Open Access model. An Article Processing Charge (APC) is applicable only after a manuscript is formally accepted. This one-time transparent fee supports the complete publication process, ensuring that your research is disseminated professionally and made freely accessible to the global community.
The APC covers essential services such as:
Word Count Range | APC (EUR) |
---|---|
150 - 1500 | € 199 |
1000 - 3000 | € 399 |
2000 - 7000 | € 599 |
ConfSeries is committed to equitable access in publishing. Waivers are available for researchers with limited financial resources, and discounts are provided through institutional collaborations. Authors wishing to apply for waivers or discuss institutional discount options may contact us at support@confseries.com.